• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Synergy CHC Announces Appointment of Erik Shields as Vice President of Beverage

    5/29/25 8:00:00 AM ET
    $SNYR
    Other Pharmaceuticals
    Health Care
    Get the next $SNYR alert in real time by email

    WESTBROOK, Maine, May 29, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that Erik Shields has been named Vice President of Beverage of Synergy, effective May 26, 2025.

    "We're excited to welcome Erik to the team and look forward to his contributions," said Jack Ross, CEO of Synergy. "With nearly two decades of experience leading national strategies, managing key accounts, and building high-performance teams, Erik brings the leadership and executional expertise needed to help scale our beverage business. As we focus on accelerating growth in this category, we're confident he will deliver an immediate and lasting impact."

    Shields brings nearly 20 years of sales leadership experience across both alcoholic and non-alcoholic beverage categories. Most recently, he was the Director of C-Store Sales at Trilliant Food & Nutrition, a leading provider of coffee and other specialty food and beverage products. His previous roles include National Account Director and Business Development Lead, with a core focus on wholesaler and distribution strategy. Over the past decade, he has built a strong reputation in the Northeast region for driving revenue growth, developing strategic partnerships, and leading with purpose. As a Certified Cicerone®, Erik also brings a deep understanding of beer and beverage category dynamics, which will support Synergy's innovation and expansion efforts across the portfolio.

    Shields joins Synergy at a pivotal time for the Company's beverage strategy, which includes the expansion of its flagship brain health brand, FOCUSfactor, into the high-growth functional beverage category. The launch of Focus + Energy Drinks—formulated with fast-acting B-vitamins and nootropics to deliver clean, convenient energy and focus—marks a major step forward in aligning the brand's cognitive health legacy with rising consumer demand for better-for-you, functional beverage options. As Vice President of Beverage, Shields will be responsible for driving go-to-market strategy, distribution, and brand execution for this new product line, helping position Synergy at the intersection of two booming wellness trends: mental performance and functional beverages.

    "I'm honored to join Synergy at such an exciting moment in its growth journey," said Erik Shields, Vice President of Beverage. "Synergy's focus on innovation, brand building, and customer-centric execution aligns well with my passion for creating scalable strategies and building high-performing teams. I look forward to partnering with Jack and the broader leadership team to accelerate the momentum already underway in the beverage division and unlock new opportunities for growth."

    About Synergy CHC Corp.

    Synergy CHC Corp. is a provider of consumer health care and lifestyle products. Synergy's current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically-tested brain health supplement that has been shown to improve memory, concentration and focus, and Flat Tummy, a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their weight management goals.

    Investor Relations

    Gateway Group

    Cody Slach

    949.574.3860

    [email protected]



    Primary Logo

    Get the next $SNYR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SNYR

    DatePrice TargetRatingAnalyst
    1/21/2025$10.00Buy
    ROTH MKM
    More analyst ratings

    $SNYR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Synergy CHC Announces Appointment of Erik Shields as Vice President of Beverage

      WESTBROOK, Maine, May 29, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that Erik Shields has been named Vice President of Beverage of Synergy, effective May 26, 2025. "We're excited to welcome Erik to the team and look forward to his contributions," said Jack Ross, CEO of Synergy. "With nearly two decades of experience leading national strategies, managing key accounts, and building high-performance teams, Erik brings the leadership and executional expertise needed to help scale our beverage business. As we focus on accelerating growth in this category, we're confident he w

      5/29/25 8:00:00 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp Reports Growth in Earnings Per Share for its First Quarter 2025 Financial Results and its Ninth Consecutive Quarter of Profitability

      WESTBROOK, Maine, May 15, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, is announcing its financial results for the three months ended March 31, 2025. "We are very pleased to report 30% growth in earnings per share year-over-year, marking our ninth consecutive quarter of profitability," said Jack Ross, CEO of Synergy. "Additionally, we expanded our EBITDA margins significantly to 24.1% compared to 19.7% in the prior year period. This performance highlights the strength of our operating model and our ongoing discipline around cost management." "We continue to make meaningful progress toward

      5/15/25 8:00:00 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. Announces First Quarter 2025 Earnings and Conference Call Information

      WESTBROOK, Maine, May 01, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that it plans to release financial results for the first quarter ended March 31, 2025, on Thursday, May 15, 2025, before the open of market trading. In conjunction with reporting first quarter 2025 results, Synergy will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT with the Company's Chief Executive Officer, Jack Ross, and the Company's Chief Financial Officer, Jaime Fickett. A live webcast of the call will be available on the Investor Relations section of Synergy's website. To access the call by

      5/1/25 4:05:00 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care

    $SNYR
    Leadership Updates

    Live Leadership Updates

    See more
    • Synergy CHC Announces Appointment of Erik Shields as Vice President of Beverage

      WESTBROOK, Maine, May 29, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that Erik Shields has been named Vice President of Beverage of Synergy, effective May 26, 2025. "We're excited to welcome Erik to the team and look forward to his contributions," said Jack Ross, CEO of Synergy. "With nearly two decades of experience leading national strategies, managing key accounts, and building high-performance teams, Erik brings the leadership and executional expertise needed to help scale our beverage business. As we focus on accelerating growth in this category, we're confident he w

      5/29/25 8:00:00 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care

    $SNYR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by Synergy CHC Corp.

      SC 13D - Synergy CHC Corp. (0001562733) (Subject)

      10/31/24 9:55:58 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G filed by Synergy CHC Corp.

      SC 13G - Synergy CHC Corp. (0001562733) (Subject)

      10/25/24 7:46:44 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care

    $SNYR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ROTH MKM initiated coverage on Synergy CHC Corp. with a new price target

      ROTH MKM initiated coverage of Synergy CHC Corp. with a rating of Buy and set a new price target of $10.00

      1/21/25 9:10:17 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care

    $SNYR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO and Chairman Ross Jack bought $10,870 worth of shares (5,300 units at $2.05), increasing direct ownership by 1% to 366,507 units (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      5/21/25 5:05:31 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • CEO and Chairman Ross Jack bought $39,350 worth of shares (14,340 units at $2.74), increasing direct ownership by 4% to 361,207 units (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      5/21/25 4:46:18 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • CEO and Chairman Ross Jack bought $59,521 worth of shares (15,200 units at $3.92), increasing direct ownership by 5% to 346,877 units (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      3/3/25 9:25:39 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care

    $SNYR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO and Chairman Ross Jack bought $10,870 worth of shares (5,300 units at $2.05), increasing direct ownership by 1% to 366,507 units (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      5/21/25 5:05:31 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • CEO and Chairman Ross Jack bought $39,350 worth of shares (14,340 units at $2.74), increasing direct ownership by 4% to 361,207 units (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      5/21/25 4:46:18 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • CEO and Chairman Ross Jack bought $59,521 worth of shares (15,200 units at $3.92), increasing direct ownership by 5% to 346,877 units (SEC Form 4)

      4 - Synergy CHC Corp. (0001562733) (Issuer)

      3/3/25 9:25:39 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care

    $SNYR
    SEC Filings

    See more
    • SEC Form 10-Q filed by Synergy CHC Corp.

      10-Q - Synergy CHC Corp. (0001562733) (Filer)

      5/15/25 8:05:55 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Synergy CHC Corp. (0001562733) (Filer)

      5/15/25 8:00:17 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • SEC Form DEFA14A filed by Synergy CHC Corp.

      DEFA14A - Synergy CHC Corp. (0001562733) (Filer)

      4/28/25 4:20:08 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care

    $SNYR
    Financials

    Live finance-specific insights

    See more
    • Synergy CHC Corp Reports Growth in Earnings Per Share for its First Quarter 2025 Financial Results and its Ninth Consecutive Quarter of Profitability

      WESTBROOK, Maine, May 15, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, is announcing its financial results for the three months ended March 31, 2025. "We are very pleased to report 30% growth in earnings per share year-over-year, marking our ninth consecutive quarter of profitability," said Jack Ross, CEO of Synergy. "Additionally, we expanded our EBITDA margins significantly to 24.1% compared to 19.7% in the prior year period. This performance highlights the strength of our operating model and our ongoing discipline around cost management." "We continue to make meaningful progress toward

      5/15/25 8:00:00 AM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. Announces First Quarter 2025 Earnings and Conference Call Information

      WESTBROOK, Maine, May 01, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that it plans to release financial results for the first quarter ended March 31, 2025, on Thursday, May 15, 2025, before the open of market trading. In conjunction with reporting first quarter 2025 results, Synergy will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT with the Company's Chief Executive Officer, Jack Ross, and the Company's Chief Financial Officer, Jaime Fickett. A live webcast of the call will be available on the Investor Relations section of Synergy's website. To access the call by

      5/1/25 4:05:00 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care
    • Synergy CHC Corp. Announces Fourth Quarter and Full Year 2024 Earnings and Conference Call Information

      WESTBROOK, Maine, March 20, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ:SNYR) ("Synergy" or the "Company"), a provider of consumer health care and lifestyle products, announced today that it plans to release financial results for the fourth quarter and full year ended December 31, 2024, on Monday, March 31, 2025, before the open of market trading. In conjunction with reporting fourth quarter and full year 2024 results, Synergy will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT with the Company's Chief Executive Officer, Jack Ross, and the Company's Chief Financial Officer, Jaime Fickett. A live webcast of the call will be available on the Investor Relations section of Syner

      3/20/25 4:05:00 PM ET
      $SNYR
      Other Pharmaceuticals
      Health Care